Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
streptokinase 1,5 MIE pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
streptokinase 250.000 IE pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
streptokinase 750.000 IE pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
cefotaxim 2 g pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
imipenem 500 mg + cilastatin 500 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
amphotericin 100 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
cisplatin 50 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
vancomycinhydrochlorid 10 g pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
erythromycinlactobionat 500 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
erythromycinlactobionat 1 g pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Drotrecogin alfa 5 mg powder for solution for injection vial |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
drotrecogin alfa 20 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
ertapenem 1 g pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
drotrecogin alfa, aktiveret 5 mg pulver til infusionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Vancomycin hydrochloride 750mg powder for infusion solution |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Gemcitabine 2g powder for infusion solution |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Trastuzumab emtansine 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Lyophilized powder for conventional release solution for infusion |
Is a |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely aciclovir (as aciclovir sodium) 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Blinatumomab 38.5 microgram powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely belatacept 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely rabbit anti-human T-lymphocyte globulin 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely anidulafungin 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely alglucosidase alfa 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Dacarbazine (as dacarbazine citrate) 1 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely dacarbazine (as dacarbazine citrate) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Dexrazoxane (as dexrazoxane hydrochloride) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Decitabine 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Clarithromycin (as clarithromycin lactobionate) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Fosaprepitant (as fosaprepitant dimeglumine) 150 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely hydroxocobalamin 2.5 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Voriconazole 200 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely verteporfin 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Vancomycin (as vancomycin hydrochloride) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Powder for conventional release solution for infusion or injection (dose form) |
Is a |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ceftaroline fosamil (as ceftaroline fosamil acetic acid solvate) 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Caspofungin (as caspofungin acetate) 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely caspofungin (as caspofungin acetate) 70 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Carmustine 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Melphalan (as melphalan hydrochloride) 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely normal human immunoglobulin 10 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Tigecycline 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely thiotepa 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Thiotepa 400 mg powder for solution for infusion bag |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Tasonermin 1 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Siltuximab 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Vedolizumab 300 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Trabectedin 1 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely trastuzumab 420 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Trastuzumab 60 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Trastuzumab deruxtecan 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely pemetrexed (as pemetrexed disodium) 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Pemetrexed (as pemetrexed disodium) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Rasburicase 1.5 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Isavuconazole (as isavuconazonium sulfate) 200 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Lenograstim 33.6 million unit powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely remifentanil (as remifentanil hydrochloride) 2 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely remifentanil (as remifentanil hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Cefalotin (as cefalotin sodium) 2 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Daptomycin 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cloxacillin (as cloxacillin sodium) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Cloxacillin (as cloxacillin sodium) 2 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ceftobiprole (as ceftobiprole medocaril sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ceftriaxone (as ceftriaxone sodium) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 2 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Ampicillin (as ampicillin sodium) 1 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Rifampicin 300 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|